These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2004-002440-96 A randomised placebo controlled trial of itraconazole in the treatment of fungal-sensitised patients with severe asthma and without ABPA. 2006-12-22 due-trials
Reported results 2004-002799-41 Iontophoresis as a possible therapy for digital ischaemia - preliminary studies in patients with scleroderma spectrum disorders 2010-03-24 due-trials
Reported results 2004-003833-15 A randomised parallel group study to investigate the effect of Seretide withdrawal in COPD using non-invasive biomarkers and physiological measurements 2007-08-01 due-trials
Reported results 2005-001824-35 Non-randomised phase II trial of Sequential Therapy of Imiquimod followed by Vaccination with TA CIN for High Grade VIN 2008-05-16 due-trials
Reported results 2005-003775-21 Effects of atorvastatin on microcirculatory endothelial function in patients with systemic sclerosis 2008-11-24 due-trials
Not reported 2005-003845-15 A cluster randomised control trial to measure the benefit of fluoride varnish in preventing dental decay when applied to the permanent teeth of children for three years in the school setting 2009-04-03 due-trials
Not reported 2006-000193-77 Protective analgesia using bupivacaine and conventional release ibuprofen versus bupivacaine and sustained release ibuprofen for postoperative pain relief in patients undergoing third molar surgery: a... 2007-12-31 due-trials
Reported results Terminated 2006-000900-17 A randomised double-blind placebo controlled trial of the oral bisphosphonate, Alendronate, plus intravenous pamidronate, in active diabetic Charcot neuroarthropathy (CN). 2010-12-06 due-trials
Not reported 2006-006032-22 TRial of Atorvastatin for the primary prevention of Cardiovascular Events in Rheumatoid Arthritis 2013-01-31 due-trials
Reported results Terminated 2006-006619-64 Randomised Controlled Trial of Lapatinib (A Her1/2 Tyrosine Kinase Inhibitor) on Epithelial Proliferation and Apoptosis in Ductal Cancer in Situ. 2010-01-12 due-trials
Reported results 2007-002571-14 The Potential use of Larval Therapy/Biogun and Silver to Reduce Colonisation of MRSA in Diabetic Foot Ulcers. 2009-03-31 due-trials
Ongoing 2008-005466-30 Effect of Perioperative AntiHER2 Therapy on Early Breast Cancer Study - Biological Phase not-yet-due
Reported results 2009-010725-39 A randomised controlled trial to measure the effects and costs of a dental caries prevention regime for young children attending primary care dental services 2015-06-16 due-trials
Reported results 2011-005151-13 Open-label Pilot Study of Memantine in Chronic Cough Patients Attending a Specialist Clinic 2013-08-14 due-trials
Ongoing 2016-000754-35 The effect of Denosumab on Pain and bone Marrow Lesions in symptomatic Knee Osteo-arthritis: A Randomised Double Blind Placebo controlled Clinical Trial not-yet-due
Ongoing 2016-002651-25 A Phase II Randomised Controlled Study of Oral Prednisolone in Early Diffuse Cutaneous Systemic Sclerosis not-yet-due
Ongoing 2016-003725-42 Does Interleukin-1 Receptor Antagonist Improve Outcome following aneurysmal Subarachnoid Haemorrhage (aSAH)? A Phase III trial not-yet-due
Ongoing 2016-004617-28 A 3-Arm Randomised Phase II Evaluation of Cediranib in Combination with Weekly Paclitaxel or Olaparib Versus Weekly Paclitaxel Chemotherapy as Second-Line Therapy for Advanced/Metastatic Endometrial C... not-yet-due
Ongoing 2016-004618-93 Evaluation of the safety of CEdiranib in the prevention of Bowel perforation in platinum-resistant Ovarian Cancer not-yet-due
Ongoing 2018-000249-38 Phase II trial of interleukin-1 receptor antagonist in intracerebral haemorrhage: BLOcking the Cytokine IL-1 in ICH not-yet-due
Exempt 2019-001825-28 Mesoangioblast-mediated exon 51 skipping for genetic correction of dystrophin, based upon a single injection in individual skeletal muscles of five non ambulant patients affected by Duchenne Muscular ... not-yet-due
Ongoing 2019-003868-42 A randomised, phase IIa treatment delayed-start trial of the oral JAK 1/2 inhibitor, baricitinib, in the treatment of adult idiopathic inflammatory myopathy not-yet-due
Ongoing 2020-001636-95 Subcutaneous and Intravenous anakinra in COVID-19 Infection - Feasibility & Pharmacokinetics/ Pharmacodynamics study not-yet-due